BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8096770)

  • 1. [Alpha 2-agonists in anesthesia and intensive medicine].
    Bischoff P; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1993 Feb; 28(1):2-12. PubMed ID: 8096770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic potency of alpha adrenergic agents after systemic administration in amphibians.
    Brenner GM; Klopp AJ; Deason LL; Stevens CW
    J Pharmacol Exp Ther; 1994 Aug; 270(2):540-5. PubMed ID: 7915313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiles of medetomidine and its antagonist, atipamezole.
    Virtanen R
    Acta Vet Scand Suppl; 1989; 85():29-37. PubMed ID: 2571275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adrenergic receptor and alpha 2 agonist--4: Applied and clinical pharmacology of alpha 2 agonist].
    Mizobe T
    Masui; 1997 Aug; 46(8):1066-70. PubMed ID: 9283162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-2 adrenergic modulation of sleep: time-of-day-dependent pharmacodynamic profiles of dexmedetomidine and clonidine in the rat.
    Seidel WF; Maze M; Dement WC; Edgar DM
    J Pharmacol Exp Ther; 1995 Oct; 275(1):263-73. PubMed ID: 7562559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.
    Armstrong JM; Lefèvre-Borg F; Scatton B; Cavero I
    J Pharmacol Exp Ther; 1982 Nov; 223(2):524-35. PubMed ID: 6127404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia.
    Gil DW; Cheevers CV; Kedzie KM; Manlapaz CA; Rao S; Tang E; Donello JE
    Anesthesiology; 2009 Feb; 110(2):401-7. PubMed ID: 19194166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
    Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the antinociceptive effects of alpha-2 adrenoceptor agonists in two substrains of Sprague-Dawley rats.
    Graham BA; Hammond DL; Proudfit HK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):511-9. PubMed ID: 9353364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clonidine, dexmedetomidine and xylazine on thermal antinociception in rhesus monkeys.
    Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1993 Feb; 264(2):762-9. PubMed ID: 8094751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
    Doze V; Chen BX; Li Z; Maze M
    Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity.
    Takano Y; Yaksh TL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):327-35. PubMed ID: 8093729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexmedetomidine decreases halothane anesthetic requirements in rats.
    Segal IS; Vickery RG; Maze M
    Acta Vet Scand Suppl; 1989; 85():55-9. PubMed ID: 2571278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of brain adrenoceptors in the corticortopin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats.
    Yorimitsu M; Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Yokotani K
    Life Sci; 2008 Feb; 82(9-10):487-94. PubMed ID: 18201726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clonidine and anesthesia].
    Boussofara M; Mtaallah MH; Nefaa MN; Kaddour C
    Tunis Med; 2004 Mar; 82(3):249-57. PubMed ID: 15382458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of intrathecal adrenergic agonists: cardiovascular and nociceptive reflexes in halothane-anesthetized rats.
    Nagasaka H; Yaksh TL
    Anesthesiology; 1990 Dec; 73(6):1198-207. PubMed ID: 1978989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats.
    Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D
    Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
    Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
    J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.